Trial Profile

DOSE-FINDING STUDY TO ASSESS THE SAFETY AND EFFECT OF SYL1001 IN PATIENTS WITH OCULAR PAIN

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 03 Oct 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tivanisiran (Primary)
Indications Ocular pain
Focus Therapeutic Use
Sponsors Sylentis

Most Recent Events

04 Apr 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
14 Mar 2016 Results and additional analysis of this clinical trial will be presented at the ARVO conference in May 2016, according to a Sylentis media release.
14 Mar 2016 Results published in a Sylentis media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com